MYO · Myomo, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-07 | GUDONIS PAUL R |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for the incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. |
Common Stock
|
146,909 |
| 2026-08-07 | Mitchell Micah |
Chief Commercial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026. |
Common Stock
|
21,559 |
| 2026-08-07 | HENRY DAVID A |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026. |
Common Stock
|
25,310 |
| 2026-08-07 | Kovelman Harry |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026. |
Common Stock
|
22,457 |
| 2026-08-07 | Kovelman Harry |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. |
Common Stock
|
55,149 |
| 2026-08-07 | HENRY DAVID A |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. |
Common Stock
|
68,644 |
| 2026-08-07 | Mitchell Micah |
Chief Commercial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. |
Common Stock
|
58,409 |
| 2026-07-13 | HENRY DAVID A |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares sold on July 13, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on July 10, 2026. Transaction was completed pursuant to an irrevocable election made by the Reporting Person on December 11, 2025. |
Common Stock
|
5,166 |
| 2026-07-10 | GUDONIS PAUL R |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on October 10, 2026. |
Common Stock
|
10,454 |
| 2026-07-10 | HENRY DAVID A |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on October 10, 2026. |
Common Stock
|
7,840 |
| 2026-06-25 | Crowley Thomas Aloysius Jr. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning on September 9, 2026. |
Common Stock
|
78,704 |
| 2026-06-25 | FEBBO WILLIAM J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning on September 9, 2026. |
Common Stock
|
78,704 |
| 2026-06-25 | KIRK THOMAS F |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning September 9, 2026. |
Common Stock
|
78,704 |
| 2026-06-25 | Morris Milton Mayo |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. |
Common Stock
|
78,704 |
| 2026-06-25 | Getz Heather C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four quarterly installments beginning on September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. |
Common Stock
|
78,704 |
| 2026-06-25 | Manko Joseph M. Jr. |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. |
Common Stock
|
78,704 |
| 2026-06-12 | Mitchell Micah |
Chief Commercial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents sale of common stock on June 12, 2026 solely to pay income taxes resulting from a vesting of restricted stock units on June 11, 2026 pursuant to an irrevocable election made on May 28, 2026. |
Common Stock
|
9,061 |
| 2026-06-12 | HENRY DAVID A |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld on June 12, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on June 11, 2026. |
Common Stock
|
10,969 |
| 2026-06-12 | Kovelman Harry |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares sold on June 12, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 11, 2026, purusant to an irrevocable election made by the Reporting Party on May 28, 2026. |
Common Stock
|
10,442 |
| 2026-06-08 | HENRY DAVID A |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld on June 8, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on June 5, 2026. |
Common Stock
|
10,050 |
| 2026-06-08 | Mitchell Micah |
Chief Commercial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents sale of common stock on June 8, 2026 solely to pay income taxes resulting from a vesting of restricted stock units on June 5, 2026 pursuant to an irrevocable election made on May 28, 2026. |
Common Stock
|
6,529 |
| 2026-06-08 | Kovelman Harry |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares sold on June 8, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 5, 2026. |
Common Stock
|
7,635 |
| 2026-06-05 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Represented weighted average purchase price. Shares were purchased in multiple lots at purchase prices ranging from $1.23 to $1.30 per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request. |
Common Stock
|
40,002 |
| 2026-05-28 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Shares were purchased in multiple lots at this purchase price per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request. |
Common Stock
|
25,000 |
| 2026-05-28 | Kovelman Harry |
Chief Medical Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents open market sale of shares. Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.035 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
11,536 |
| 2026-05-27 | Kovelman Harry |
Chief Medical Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents open market sale of shares. Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.005 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
20,464 |
| 2026-05-18 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Represents weighted average purchase price. Shares were purchased in multiple lots at purchase prices ranging from $0.815 to $0.91 per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request. |
Common Stock
|
43,401 |
| 2026-05-15 | Manko Joseph M. Jr. |
Director, 10% Owner |
Buy↑
|
MYO
(I)
|
30,367 |
| 2026-05-15 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Represents weighted average purchase price. Shares were purchased in multiple lots, at purchase prices ranging from $0.9041 to $0.91 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
31,605 |
| 2026-05-14 | Manko Joseph M. Jr. |
Director, 10% Owner |
Buy↑
|
MYO
(I)
|
170,830 |
| 2026-05-14 | Mitchell Micah |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents sale of common stock on May 14, 2026 in a series of open market transactions. Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $0.85 to $0.889 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
90,231 |
| 2026-04-14 | FEBBO WILLIAM J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's vest in their entirety on the first anniversary of the grant date. |
Common Stock
|
45,000 |
| 2026-04-14 | FEBBO WILLIAM J |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-13 | HENRY DAVID A |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares sold on April 13, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on April 12, 2026. Transaction was conpleted pursuant to an irrevocable election made by the Reporting Party on December 11, 2025. |
Common Stock
|
3,953 |
| 2026-04-10 | GUDONIS PAUL R |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026. |
Common Stock
|
16,666 |
| 2026-04-10 | HENRY DAVID A |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026. |
Common Stock
|
12,500 |
| 2026-03-16 | Getz Heather C |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchase in a single transaction. |
Common Stock
|
20,000 |
| 2026-03-13 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Represents weighted average purchase price. Shares were purchased in multiple lots, at purchase prices ranging from $0.70 to $0.71 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
72,000 |
| 2026-03-12 | Getz Heather C |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Shares were purchased in multiple lots at prices ranging from $0.72 to $0.73 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. Represents weighted average purchase price |
Common Stock
|
70,000 |
| 2026-01-12 | GUDONIS PAUL R |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing exployees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on April 12, 2026. |
Common Stock
|
11,637 |
| 2026-01-12 | HENRY DAVID A |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing exployees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on April 12, 2026. |
Common Stock
|
8,727 |
| 2025-11-21 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Shares were purchased in multiple lots, each executing at $0.72 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
2,535 |
| 2025-11-20 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Shares were purchased in multiple lots, each executing at $0.72 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
4,902 |
| 2025-11-19 | Crowley Thomas Aloysius Jr. |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average purchase price Represents shares held by the Reporting Person's immediate family member. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. |
Common Stock
(I)
|
385 |
| 2025-11-18 | Crowley Thomas Aloysius Jr. |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents an open market purchase in a single transaction. |
Common Stock
|
4,000 |
| 2025-09-09 | GUDONIS PAUL R |
Director, Chief Executive Officer |
Gift↓
Filing footnotes — Common Stock (Direct)
Represents a gift of 10,000 shares by the Reporting Party to a third party. This represents a bona fide gift where the Reporting Party is not receiving any direct or indirect benefit. |
Common Stock
|
10,000 |
| 2025-08-25 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Shares were purchased in multiple lots, each executing at $1.15 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
50,000 |
| 2025-08-18 | KIRK THOMAS F |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Shares were purchased in two transactions, each executing at $1.10 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. |
Common Stock
|
50,000 |
| 2025-08-15 | GUDONIS PAUL R |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents open market purchases. Represents volume weighted average purchase price. Shares purchased in multiple lots at purchase prices ranging from $0.9289 to $0.9687 per share. Reporting Party agrees to provide details of these transactions to the SEC upon request. |
Common Stock
|
50,000 |
| 2025-06-30 | Kovelman Harry |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents sale of shares on June 30, 2025, solely to cover income taxes on the vesting of restricted stock units on June 28, 2025, pursuant to an irrevocable election made by the Reporting Party on May 12, 2025. |
Common Stock
|
13,054 |